Imara Inc. (IMRA)

Trade IMRA now with
1/20/2021 7:05:32 AM Imara Names Kenneth Attie SVP And Chief Medical Officer
1/6/2021 7:13:38 AM Imara Reports Phase 2a Clinical Trial Results Of IMR-687 In Adult Patients With Sickle Cell Disease
11/17/2020 7:11:29 AM Imara Appoints Lynette Hopkinson As SVP Of Regulatory
8/25/2020 7:24:41 AM Imara Receives Orphan Drug Designation From European Commission For IMR-687
8/14/2020 7:13:15 AM Imara Q2 Net Loss Attributable To Stockholders $10.2 Mln Or $0.59/Shr Vs Loss $5.4 Mln Or $7.68/Shr Last Year
6/24/2020 7:14:17 AM IMARA Gets Orphan Drug Designation For IMR-687 For Treatment Of Beta-thalassemia
5/4/2020 7:19:26 AM Imara Appoints Stephen Migausky As General Counsel